Jeff Jones Stock Analyst Profile - Oppenheimer Research Coverage - Stocknear

Jeff Jones

Stock Analyst at Oppenheimer

(3.7)
# 2391
Out of 5,506 analysts
118
Total ratings
Success rate
Average return

28 Stocks

Name Action PT Current % Upside Ratings Updated
KYMR Kymera Therapeutics
Maintains: Outperform
53 63
57.9 8.81% 6 Oct 1, 2025
PTHS Pelthos Therapeutics
Initiates Coverage On: Outperform
50
26.67 87.48% 1 Sep 2, 2025
CMMB Chemomab Therapeutic...
Maintains: Outperform
10 25
2.72 819.12% 9 Aug 27, 2025
CRBP Corbus Pharmaceutica...
Maintains: Outperform
56 53
14.83 257.38% 10 Aug 6, 2025
AVBP ArriVent BioPharma
Maintains: Outperform
39 44
19.84 121.77% 3 Jun 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 15
n/a n/a 4 May 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 25
4.02 521.89% 3 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 17
3.93 332.57% 4 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
15 17
7.19 136.44% 5 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 86
34.21 151.39% 2 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 18
8.21 119.24% 4 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 5 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
22 16
3.66 337.16% 7 Nov 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
10 9
3.6 150% 10 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 45
1.52 2860.53% 6 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 4 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 3 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
32 30
n/a n/a 3 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
13 15
n/a n/a 3 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Jun 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28800
n/a n/a 3 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
13
n/a n/a 2 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
15
1.44 941.67% 5 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
75
n/a n/a 2 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 150
n/a n/a 6 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1600 1100
5.43 20157.83% 2 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
193
n/a n/a 1 Jul 18, 2022